You just read:

Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia

News provided by

Avillion Group

Jan 09, 2014, 08:47 ET